# Tiet AI S.L.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tiet-ai-s-l

- Industry: Software
- Headquarters: Madrid, Spain
- Website: www.tiet.ai
- Total disclosed funding: $3M
- Latest round: Seed (Apr 22, 2026)
- Investors on record: 4

## About

Tiet AI S.L. offers innovative solutions within the European healthcare landscape, focusing on data standardization and integration. The company was co-founded by CEO Roberto Cruz and CTO David Rey. It operates from its headquarters in Madrid, Spain and founded in 2024. In April 2026, Tiet AI S.L. raised EUR 2.5 million in seed funding co-led by Plus Partners and JME Ventures with participation from Archipelago Next and Banco Sabadell.

Tiet AI S.L. provides an AI-native data platform specifically designed for the European healthcare sector, emphasizing interoperability, compliance, and automation. The platform integrates various clinical data sources, standardizes data using FHIR (Fast Healthcare Interoperability Resources), and maintains governance under the European Health Data Space (EHDS). Key features include HealthDCAT-AP catalogue publishing, OMOP dataset management, and Secure Processing Environments, addressing essential use cases such as prior authorization and clinical documentation. Tiet AI serves healthcare providers, clinical labs, healthtech companies, and researchers across various European markets, ensuring compliance with EHDS by 2027.

Tiet AI S.L. provides an AI-native data platform specifically designed for the European healthcare sector, emphasizing interoperability, compliance, and automation. The platform integrates various clinical data sources, standardizes data using FHIR (Fast Healthcare Interoperability Resources), and maintains governance under the European Health Data Space (EHDS). Key features include HealthDCAT-AP catalogue publishing, OMOP dataset management, and Secure Processing Environments, addressing essential use cases such as prior authorization and clinical documentation. Tiet AI serves healthcare providers, clinical labs, healthtech companies, and researchers across various European markets, ensuring compliance with EHDS by 2027.

## Funding rounds

- Seed, Apr 22, 2026, $3M — Banco Sabadell, JME Ventures, Archipelago Next, Plus Partners

## Investors

- Banco Sabadell — Seed
- JME Ventures (https://capitalatlas.ai/funds/jme-ventures) — Seed
- Archipelago Next (https://capitalatlas.ai/funds/archipelago-next) — Seed
- Plus Partners (https://capitalatlas.ai/funds/plus-partners) — Seed